CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons
Open accessPublished version of a preprint
Abstract
CRISPR/Cas9-based functional genomics have transformed our ability to elucidate mammalian cell biology. However, most previous CRISPR-based screens were conducted in cancer cell lines rather than healthy, differentiated cells. Here, we describe a CRISPR interference (CRISPRi)-based platform for genetic screens in human neurons derived from induced pluripotent stem cells (iPSCs). We demonstrate robust and durable knockdown of endogenous genes in such neurons and present results from three complementary genetic screens. First, a survival-based screen revealed neuron-specific essential genes and genes that improved neuronal survival upon knockdown. Second, a screen with a single-cell transcriptomic readout uncovered several examples of genes whose knockdown had strikingly cell-type-specific consequences. Third, a longitudinal imaging screen detected distinct consequences of gene knockdown on neuronal morphology. Our results highlight the power of unbiased genetic screens in iPSC-derived differentiated cell types and provide a platform for systematic interrogation of normal and disease states of neurons. VIDEO ABSTRACT.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 20 cited sources checked · 0 supported · 0 flagged
- Findingown data
CRISPRi produces strong and lasting reduction of endogenous gene expression in human neurons made from iPSCs.
“We demonstrate robust and durable knockdown of endogenous genes in such neurons”
- Also stated in: § Robust CRISPR interference in human iPSC-derived neurons · boosted
“Our platform thus enables potent CRISPRi knockdown of endogenous genes in iPSC-derived neurons.”
Quote in the paperSubstantial claim - Also stated in: § Robust CRISPR interference in human iPSC-derived neurons · boosted
- Findingown data
Expression of the CRISPRi machinery and/or sgRNAs did not affect neuronal activity measured by calcium imaging.
“or activity as evaluated by calcium imaging (Fig. S1F and Movies S1, S2).”
Quote in the paperSubstantial claim - Findingown data
Expression of the CRISPRi machinery and/or sgRNAs did not produce detectable DNA damage in iPSCs.
“We found that expression of CRISPRi machinery and/or sgRNAs did not cause detectable DNA damage (Fig. S1C,D)”
Quote in the paperSubstantial claim - Findingown data
The vast majority of sgRNAs that altered survival in pooled screens also altered survival in the arrayed longitudinal survival analysis.
“the vast majority of sgRNAs that altered survival in pooled screens also altered survival in our arrayed longitudinal survival analysis (Fig. 7D).”
Quote in the paperSubstantial claim - Findingown data
The vast majority of neuron-essential genes were detectable at the transcript level.
“The vast majority of neuron-essential genes were detectable at the transcript level, further supporting the specificity of our screen results.”
Quote in the paperSubstantial claim
- Findingown data
Two independent sgRNAs targeting PPP1R12C caused continued proliferation instead of neuronal differentiation in a subset of iPSCs.
“we observed that two independent sgRNAs targeting PPP1R12C each caused continued proliferation instead of neuronal differentiation in a subset of iPSCs (Fig. S4F,G)”
Quote in the paperSubstantial claim - Findingown data
Clustering gene knockdown groups by differential expression found transcriptomic signatures associated with knockdown of functionally related genes.
“By clustering gene knockdown groups based on the signature of differential gene expression, we found transcriptomic signatures associated with knockdown of functionally related genes (Fig. 4C).”
Quote in the paperSubstantial claim - Findingown data
Hierarchical clustering of individual sgRNAs based on morphology features led to coclustering of the two sgRNAs targeting a given gene for most genes.
“hierarchical clustering of individual sgRNAs based on these features led to coclustering of the two sgRNAs targeting a given gene for the majority of genes (Fig. 7E).”
Quote in the paperSubstantial claim - Findingown data
Knockdown of PPCDC, UROD, and MAT2A was less toxic to neurons in the presence of astrocytes.
“we identified a small number of genes, including PPCDC, UROD and MAT2A, for which knockdown was less toxic in the presence of astrocytes (Fig. 3F).”
Quote in the paperSubstantial claim - Findingown data
Neuronal dependence on the cholesterol biogenesis pathway was validated pharmacologically with the HMG-CoA reductase inhibitor mevastatin.
“We validated the strong neuronal dependence on the cholesterol biogenesis pathway pharmacologically using the HMG-CoA reductase inhibitor mevastatin (Fig. 2E)”
Quote in the paperSubstantial claim - Findingown data
In both iPSCs and neurons, the two sgRNA groups targeting the same gene tended to cluster in tSNE plots.
“In both iPSCs and neurons, the two sgRNA groups expressing sgRNAs targeting the same gene tended to form clusters in t-Distributed stochastic neighbor embedding (tSNE) plots (Fig. S5B)”
Quote in the paperSubstantial claim - Findingown data
CRISPRi knockdown of HMGCR can be partially rescued by supplementing mevalonate.
“and found that CRISPRi knockdown of HMG-CoA reductase (HMGCR) can be partially rescued by supplementing its product mevalonate (Fig. 2F).”
Quote in the paperSubstantial claim - Findingown data
Knockdown of MAP3K12, MAPK8, CDKN1C, and EIF2AK3 enhanced neuronal survival.
“we identified several genes that specifically enhanced neuronal survival when knocked down, including MAP3K12 (encoding dual leucine zipper kinase DLK), MAPK8 (encoding Jun kinase JNK1), CDKN1C (encoding the cyclin-dependent kinase inhibitor p57) and EIF2AK3 (encoding the eIF2alpha kinase PERK) (Table S1).”
Quote in the paperSubstantial claim - Findingown data
MAT2A knockdown in neurons caused differential expression of thousands of genes.
“In neurons, however, knockdown of MAT2A caused differential expression of thousands of genes (Fig. 6D, Table S3).”
Quote in the paperSubstantial claim - Findingown data
TMP addition starting at the iPSC stage resulted in robust CRISPRi activity in iPSCs and neurons.
“TMP addition starting at the iPSC stage resulted in robust CRISPRi activity in iPSCs and neurons (Fig. S4D)”
Quote in the paperSubstantial claim - Findingown data
TMP addition starting at the neuronal stage resulted in moderate CRISPRi activity.
“and TMP addition starting at the neuronal stage resulted in moderate CRISPRi activity (Fig. S4E).”
Quote in the paperNot a substantial claim - Findingown data
Genes downregulated in neurons upon MAT2A knockdown were enriched for neuron-specific functions.
“Genes downregulated in neurons in response to MAT2A knockdown were enriched for neuron-specific functions (Fig. 6E)”
Quote in the paperSubstantial claim - Findingown data
UQCRQ knockdown had similar transcriptomic consequences in iPSCs and neurons, including upregulation of mitochondrially encoded electron transport chain components and ribosomal proteins.
“knockdown of UQCRQ had similar transcriptomic consequences in both iPSCs and neurons – upregulation of mitochondrially encoded electron transport chain components and of ribosomal proteins (Fig. 5C, Table S3).”
Quote in the paperNot a substantial claim - Findingown data
Neuron-essential genes were expressed at significantly higher levels than non-essential genes in iPSC-derived neurons.
“As a group, neuron-essential genes were expressed at significantly higher levels than non-essential genes in iPSC-derived neurons (one-sided Mann-Whitney U test, Fig. S3B).”
Quote in the paperNot a substantial claim - Findingown data
The arrayed screening platform uncovered gene-specific effects on longitudinal survival and neuronal morphology.
“our arrayed screening platform uncovered gene-specific effects on longitudinal survival and neuronal morphology.”
Quote in the paperSubstantial claim - Findingown data
For most genes, knockdown levels greater than 80% were achieved (24/27 in iPSCs, 18/27 in neurons).
“For most genes (24/27 in iPSCs, 18/27 in neurons) knockdown levels of greater than 80% were achieved.”
Quote in the paperSubstantial claim - Findingown data
MAP3K12 knockdown induced expression of neuritin (NRN1).
“Lastly, MAP3K12 knockdown induced expression of neuritin (NRN1)”
Quote in the paperNot a substantial claim - Findingown data
CRISPR interference does not cause DNA damage in the tested cells.
“First, it does not cause DNA damage (Fig. S1C,D)”
Quote in the paperSubstantial claim - Findingown data
In the population cultured without TMP, none of the sgRNAs showed strong phenotypes compared to cells with TMP added at the iPSC stage.
“In the population cultured without TMP, none of the sgRNAs showed strong phenotypes compared to cells to which TMP was added at the iPSC stage (Fig. 3I), confirming the tight control of the inducible system.”
Quote in the paperSubstantial claim - Findingown data
For most hit genes, two or three sgRNAs in the library produced strong phenotypes.
“For the majority of hit genes, two or three sgRNAs in the library resulted in strong phenotypes (Fig. S2C,D), justifying the use of five sgRNAs/gene in the primary screen library.”
Quote in the paperSubstantial claim - Findingown data
UBA1 knockdown caused neuron-specific induction of many genes, including heat shock proteins.
“caused neuron-specific induction of a large number of genes (Fig. 5D, Table S3), including those encoding heat shock proteins (cytosolic chaperones HSPA8 and HSPB1 and endoplasmic reticulum chaperones HSPA5 and HSP90B1)”
Quote in the paperSubstantial claim - Findingown data
Knockdown of MMAB, UBA1, and PPP2R2A was more toxic to neurons in the presence of astrocytes.
“We also identified a small number of other genes, including MMAB, UBA1 and PPP2R2A, for which knockdown was more toxic in the presence of astrocytes (Fig. 3F).”
Quote in the paperNot a substantial claim - Findingown data
UQCRQ is essential in both iPSCs and neurons.
“UQCRQ is essential in both cell types (Fig. 5B)”
Quote in the paperNot a substantial claim - Findingown data
MAT2A knockdown in iPSCs did not substantially affect expression of any gene other than MAT2A itself.
“Knockdown of MAT2A in iPSCs did not substantially affect the expression of any gene other than MAT2A itself (Fig. 6C).”
Quote in the paperSubstantial claim - Findingown data
Knockdown of different genes resulted in gene-specific transcriptomic signatures rather than a generic dying-cell signature.
“Rather, knockdown of different genes resulted in gene-specific transcriptomic signatures (Fig. 4C).”
Quote in the paperSubstantial claim - Findingown data
Knockdown of PGGT1B promoted neurite growth and branching.
“Knockdown of the geranylgeranyltransferase PGGT1B promoted both neurite growth and branching”
Quote in the paperNot a substantial claim - Findingown data
Knockdown of cholesterol and fatty acid biosynthesis genes caused induction of other genes in the same pathway.
“knockdown of genes involved in cholesterol and fatty acid biosynthesis, including HMGCS1, HMGCR, PMVK, MVK, MMAB, and HACD2, caused induction of other genes in the same pathway (Fig. 4C, Table S3).”
Quote in the paperNot a substantial claim - Findingown data
Gene knockdown did not interfere with differentiation to glutamatergic neurons.
“Based on the expression of canonical marker genes, we excluded the possibility that gene knockdown interfered with differentiation to glutamatergic neurons (Fig. S5A).”
Quote in the paperSubstantial claim - Findingown data
TFRC mRNA knockdown was robust in iPSCs and in i3Neurons for several weeks after differentiation.
“Knockdown of TFRC mRNA was robust in iPSCs and in i3Neurons for several weeks after differentiation (Fig. 1B,C).”
Quote in the paperSubstantial claim - Findingown data
Knockdown of UBQLN2, GRN, and CDH2 was validated by qRT-PCR, Western blot, and/or immunofluorescence.
“We also validated knockdown of three additional genes, UBQLN2 (Fig. 1D,E), GRN (Fig. 1F,G) and CDH2 (Fig. S1B) by qRT-PCR, Western blot, and/or immunofluorescence.”
Quote in the paperSubstantial claim - Findingown data
Phenotypes observed when knockdown was induced at the iPSC stage versus the neuronal stage were highly correlated (r = 0.98).
“Phenotypes observed in these two conditions were highly correlated (r = 0.98, Fig. 3J)”
Quote in the paperSubstantial claim - Findingown data
Longitudinal imaging revealed gene-specific temporal patterns of toxicity caused by knockdown of different genes.
“longitudinal imaging provided additional information on the timeline of toxicity caused by knockdown of different genes and revealed gene-specific temporal patterns (Fig. 7D,E).”
Quote in the paperSubstantial claim - Findingown data
Neuronal phenotypes in the presence or absence of astrocytes were highly correlated.
“Neuronal phenotypes in the presence or absence of astrocytes were highly correlated (Fig. 3D,E and Fig. S4A)”
Quote in the paperSubstantial claim - Findingown data
MAP3K12 knockdown in neurons caused downregulation of HRK, APP, and JUN.
“we observed downregulation of the pro-apoptotic BCL-2 protein Harakiri/DP5 (encoded by HRK), the neurodegeneration-associated amyloid precursor protein (APP), and the pro-apoptotic transcription factor JUN”
Quote in the paperSubstantial claim - Findingown data
The dual-degron CRISPRi construct had no CRISPRi activity in iPSCs or neurons in the absence of TMP.
“In the absence of TMP, the double-degron construct had no CRISPRi activity in iPSCs or neurons (Fig. S4D).”
Quote in the paperSubstantial claim - Findingown data
Neurite length and the number of neurite trunks were under independent genetic control.
“Neurite length and the number of neurite trunks were under independent genetic control (Fig. 7G).”
Quote in the paperNot a substantial claim - Findingown data
GSEA found enrichment of distinct survival-related gene groups in neurons compared to iPSCs, including genes associated with sterol metabolism.
“we found enrichment of distinct groups of survival-related genes in neurons compared to iPSCs, such as genes associated with sterol metabolism (Fig. S3A).”
Quote in the paperSubstantial claim - Findingown data
After quality control in the CROP-Seq analysis, a single sgRNA could be assigned to approximately 15,000 iPSCs and 8,400 neurons.
“After quality control, a single sgRNA could be assigned to ~15,000 iPSCs and ~8,400 neurons”
Quote in the paperNot a substantial claim - Study design and conductown data
The CRISPRi-i3N iPSC line used in the study had a normal karyotype.
“A normal karyotype was confirmed for CRISPRi-i3N iPSCs (Fig. S1A).”
Quote in the paperNot a substantial claim - Premisecitation
CRISPRi avoids the widespread off-target effects that are intrinsic to RNAi-based screening.
“CRISPRi represents an important advance over RNAi, since it lacks the pervasive off-target effects (Gilbert et al., 2014) inherent to RNAi-based screening approaches (Adamson et al., 2012; Jackson et al., 2003; Kaelin, 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
DNA damage caused by CRISPR nuclease is highly toxic to iPSCs and untransformed cells.
“since CRISPRn-associated DNA damage is highly toxic to iPSCs and untransformed cells (Haapaniemi et al., 2018; Ihry et al., 2018; Schiroli et al., 2019).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationown data
Gene functions can vary across distinct cell types.
“consistent with the idea that gene functions can vary across distinct cell types.”
Quote in the paperSubstantial claim - Study design and conductown data
sgRNA frequencies were highly correlated between independently cultured experimental replicates in the primary screen.
“We observed highly correlated sgRNA frequencies between independently cultured experimental replicates (Fig. S2A), supporting the robustness of these measurements.”
Quote in the paperSubstantial claim - Interpretationcitation
CRISPR interference lacks the non-specific p53-mediated toxicity that CRISPR nuclease approaches show in iPSCs and untransformed cells.
“and thus lacks the non-specific p53-mediated toxicity observed with CRISPRn approaches in iPSCs and untransformed cells (Haapaniemi et al., 2018; Ihry et al., 2018).”
Quote in the paperSubstantial claim0 of 2 sources checked - Study design and conductown data
The CRISPRi-i3N iPSC line used for further experiments had a normal karyotype.
“Karyotype testing (Cell Line Genetics) was normal for the clonal line used for further experiments in this study, which we termed CRISPRi-i3N iPSCs.”
Quote in the paperNot a substantial claim - Interpretationown data
The vast majority of hits from the original screen are essential for neuronal survival rather than differentiation.
“indicating that the vast majority of hits identified from the original screen are indeed essential for neuronal survival, rather than differentiation (Fig. 3H).”
Quote in the paperSubstantial claim - Study design and conductown data
The CRISPRi-i3N iPSC line used had heterozygous integration of dCas9-BFP-KRAB, determined by PCR genotyping.
“Clones with heterozygous integration of dCas9-BFP-KRAB (determined using PCR genotyping) were used for further testing.”
Quote in the paperNot a substantial claim - Study design and conductown data
Functional CRISPRi activity in the NCRM5-derived line was verified by GRN immunocytochemistry.
“including functional CRISPRi activity (verified by GRN immunocytochemistry)”
Quote in the paperSubstantial claim - Study design and conductown data
The NCRM5-derived clones used had heterozygous integration of dCas9-BFP-KRAB and TO-hNGN2-BSD-mApple, determined by PCR genotyping.
“Clones with heterozygous integration of dCas9-BFP-KRAB and TO-hNGN2-BSD-mApple (determined using PCR genotyping) were used for further testing”
Quote in the paperSubstantial claim - Interpretationown data
Screens in differentiated, non-cancerous cell types could reveal novel cell-type-specific gene functions.
“we reasoned that screens in differentiated, non-cancerous cell types could elucidate novel, cell-type specific gene functions.”
Quote in the paperSubstantial claim - Interpretationcitation
Because CRISPR interference is inducible and reversible, it enables time-resolved dissection of human gene function.
“enabling the time-resolved dissection of human gene function.”
Quote in the paperSubstantial claim - Study design and conductown data
Three individual sgRNAs were so toxic that they prevented longitudinal imaging and were removed from further analysis.
“Three individual sgRNAs were so toxic that they prevented longitudinal imaging, and were removed from further analysis.”
Quote in the paperNot a substantial claim - Interpretationown data
Knockdown phenotypes of specific genes occupy distinct regions in a high-dimensional neuronal morphology space.
“Conceptually, knockdown phenotypes of specific genes occupy distinct regions in a highdimensional neuronal morphology space (Fig. 7E,G).”
Quote in the paperSubstantial claim - Interpretationreasoning
Partial knockdown by CRISPR interference enables functional characterization of essential genes, as demonstrated in this study.
“thereby enabling functional characterization of essential genes, as demonstrated in this study.”
Quote in the paperSubstantial claim- Rests on an assumption: CRISPR interference reduces gene expression partially rather than completely eliminating it.
- Premisecitation
A pathway involving DLK, JNK, and PERK has previously been implicated in neuronal death.
“A pathway involving DLK, JNK and PERK has previously been implicated in neuronal death (Ghosh et al., 2011; Huntwork-Rodriguez et al., 2013; Larhammar et al., 2017; Miller et al., 2009; Pozniak et al., 2013; Watkins et al., 2013; Welsbie et al., 2013), validating our approach.”
Quote in the paperSubstantial claim0 of 3 sources checked - Study design and conductown data
Neuronal differentiation of the NCRM5-derived line was verified visually and with TUJ1 immunocytochemistry.
“and neuronal differentiation (verified visually and with TUJ1 immunocytochemistry).”
Quote in the paperSubstantial claim - Study design and conductown data
In the primary screen analysis, a hit-strength cutoff was chosen so that the false-discovery rate was less than 0.05.
“Based on the distribution of all the products, a cutoff value was chosen to make sure the false-discovery rate (FDR) is less than 0.05.”
Quote in the paperSubstantial claim
- May combine two claims. 20
- Classified as probably not a substantial claim. 20
May combine two claims.
Findingown dataExpression of the CRISPRi machinery and/or sgRNAs did not affect neuronal differentiation.
“and did not affect neuronal differentiation (Fig. S1E)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe screen identified a shared core set of essential genes plus additional iPSC-specific and neuron-specific essential genes.
“This analysis revealed a shared core set of essential genes, as expected, and additional iPSC-specific and neuron-specific essential genes (Fig. 2D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOnly a few genes showed high similarity in transcriptomic changes between iPSCs and neurons; most genes induced distinct responses.
“only a few genes, including SQLE, MMAB, MVK, UQCRQ, and ATP5B, showed high similarity (similarity score > 0.15) in the transcriptomic changes they induced in iPSCs versus neurons. Knockdown of most genes induced distinct transcriptomic responses in the two cell types.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMAT2A is essential in neurons but not iPSCs.
“MAT2A is essential in neurons, but not iPSCs (Fig. 6B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datasgRNAs targeting PPP1R12C were strongly enriched when TMP was added at the iPSC stage, but this phenotype was substantially weaker when TMP was added at the neuron stage.
“sgRNAs targeting PPP1R12C were strongly enriched when TMP was added at the iPSC stage, but this phenotype was substantially weaker when TMP was added at the neuron stage.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMAP3K12 knockdown caused downregulation of many cytoskeletal organization proteins and upregulation of specific synaptotagmins.
“MAP3K12 knockdown caused downregulation of a vast array of proteins involved in cytoskeletal organization, and upregulation of specific synaptotagmins”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMAP3K12 knockdown in neurons caused upregulation of ribosomal genes and POU4F1.
“Ribosomal genes and the anti-apoptotic transcription factor Brn3a (encoded by POU4F1) were upregulated.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataKnockdown phenotypes of hit genes were strongly correlated between neurons at different time points but less correlated between neurons and iPSCs.
“Knockdown phenotypes of hit genes were strongly correlated between neurons at different time points, but distinctly less correlated between neurons and iPSCs (Fig. 2C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAll positive hits and most negative hits from the primary screen were confirmed in the pooled validation screen in iPSCs and neurons.
“In both iPSCs and neurons, all positive hits and most of the negative hits from the primary screen were confirmed in the validation screen (Fig. 3C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNeither CRISPRi machinery nor non-targeting sgRNAs affected neurite growth.
“or neurite growth (Fig. S6C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNeither CRISPRi machinery nor non-targeting sgRNAs affected neuronal survival.
“We found that neither CRISPRi machinery nor non-targeting sgRNAs affected neuronal survival (Fig. S6B)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUBA1 is essential in both neurons and iPSCs.
“knockdown of the essential E1 ubiquitin activating enzyme, UBA1 (Fig. 5B)”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe median number of genes detected per cell in the CROP-Seq dataset was approximately 5,000 for iPSCs and 4,600 for neurons.
“Median number of genes detected per cell was around 5,000 for iPSCs and 4,600 for neurons.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe mean reads per cell in the CROP-Seq dataset were approximately 84,000 for iPSCs and 91,000 for neurons.
“The mean reads per cell was around 84,000 for iPSCs and 91,000 for neurons.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe i3Neuron platform yields large numbers of highly uniform neurons, which is necessary for robust population-based screens.
“which yields large quantities of highly homogeneous neurons, a prerequisite for robust population-based screens.”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationInduced expression of different transcription factors yields other neuron types, such as motor neurons and inhibitory neurons.
“induced expression of different transcription factors yield other types of neurons, such as motor neurons (Hester et al., 2011; Shi et al., 2018) and inhibitory neurons (Yang et al., 2017).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone giveniPSC-derived neurons do not fully recapitulate all features of mature or aging neurons in the human brain.
“Despite their usefulness, iPSC-derived neurons have limitations – in particular, they do not fully recapitulate all features of mature (or aging) neurons in the human brain.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCRISPR interference is inducible and reversible.
“Second, it is inducible and reversible (Gilbert et al., 2014)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gilbert et al., 2014 source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe large-scale CRISPRi screen in human iPSC-derived neurons uncovered genes controlling neuronal survival but not cancer cell or iPSC survival.
“our large-scale CRISPRi screen in human iPSC-derived neurons uncovered genes that control the survival of neurons, but not cancer cells or iPSCs”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
Interpretationnone givenNeurons are a highly specialized and disease-relevant cell type, so certain human gene functions must be studied in these cells.
“Neurons are a highly specialized and disease-relevant cell type, and thus it is crucial to study certain human gene functions in these cells.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNgn2-driven generation yields glutamatergic neurons.
“In addition to the Ngn2-driven generation of glutamatergic neurons (Fernandopulle et al., 2018; Wang et al., 2017; Zhang et al., 2013) used here”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataIn the pooled validation screen, cells were transduced at 70% MOI and selected to obtain a population that was approximately 85% BFP-positive.
“CRISPRi-i3N iPSCs were transduced with the pool at 70% MOI (quantified as fraction of BFP-positive cells by flow cytometry) and were transduced cells selected by 1 ug/ml of puromycin to obtain a population of cells that was ~85% BFP-positive.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataIn the pooled validation screen, mono-culture neuronal samples had library representations of approximately 35,000 cells per library element on Day 14 and approximately 28,000 on Day 28.
“the library representation was ~35,000 cells / library element on Day 14 and ~28,000 cells / library element on Day 28.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenIn the CROP-Seq analysis, an sgRNA was assigned to a cell only if its UMI count exceeded 4 standard deviations above the mean UMI count of all sgRNAs.
“For a given cell, sgRNA(s) whose UMI counts were greater than 4 standard deviations of the mean UMI counts of all sgRNAs were assigned to that cell as its identity.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn the pooled validation screen, the Day 0 sample had a library representation of approximately 9,000 cells per library element.
“approximately 2 million of these cells were harvested as Day 0 sample (corresponding to a library representation of ~9,000 cells/library element)”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenIn the CROP-Seq analysis, only cells with a single assigned sgRNA were retained for further analysis.
“Cells with only one assigned sgRNA were retained for further analysis.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenIn the longitudinal imaging screen, a gene targeted by two sgRNAs was discarded if the correlation between the two sgRNAs was less than 0.8.
“a gene was discarded if it was targeted by two sgRNAs and the correlation of the two sgRNAs was less than 0.8.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe primary CRISPRi screen achieved an initial MOI of approximately 15%, corresponding to a library representation of approximately 450 cells per library element.
“The initial MOI, quantified as the fraction of BFP-positive cells by flow cytometry, was ~15%, corresponding to a library representation of ~450 cells per library element.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn the pooled validation screen, co-culture neuronal Day 14 samples had a library representation of approximately 50,000 neurons per library element.
“Day 14 neurons from each replicate of co-culture experiment were harvested, the library representation was ~50,000 neurons/library element.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn the pooled validation screen, Day 10 iPSC samples had a library representation of approximately 9,000 cells per library element.
“Approximately 2 million of Day 10 iPSCs from each replicate were harvested, corresponding to a library representation of ~9,000 cells/library element.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenCROP-Seq was performed at a low multiplicity of infection to minimize double infection.
“CRISPRi-i3 N iPSCs were infected with a pool of selected sgRNAs in the CROP-Seq vector pMK1334 at a low multiplicity of infection to minimize double infection.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe 192 sgRNAs used in the pooled validation screen were verified by Sanger sequencing.
“192 sgRNAs, including 184 sgRNAs targeting 92 selected hit genes from the primary screen (two sgRNAs per gene) and 8 non-targeting control sgRNAs, were individually cloned into the secondary screening vector pMK1334 and verified by Sanger sequencing.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataIn the neuronal survival screen, estimated library representation was approximately 410 cells per library element on Day 14, approximately 380 on Day 21, and approximately 330 on Day 28.
“the estimated library representation for these time points was ~410 cells/library element on Day 14, ~380 cells/library element on Day 21, and ~330 cells/library element on Day 28.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenFor each target gene in the CROP-Seq analysis, only the top 50% of cells with the best on-target knockdown were retained.
“For each target gene, the top 50% cells with best on-target knockdown were retained.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn the pooled validation screen, sgRNA-level knockdown phenotype scores were normalized by subtracting the median from non-targeting control sgRNAs.
“Subsequently, knockdown phenotype scores for each sgRNA were calculated as LFCs of sgRNA counts between two samples and were normalized by subtracting the median of non-targeting control sgRNAs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAfter puromycin treatment in the primary screen, 83% of cells expressed high levels of BFP.
“At the end of treatment, cells were assessed by flow cytometry (83% expressed high levels of BFP)”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The AAVS1 locus, where the inducible Ngn2 transgene was integrated, lies within the PPP1R12C gene.
“Interestingly, the AAVS1 locus, into which the inducible Ngn2 transgene was integrated, resides within the PPP1R12C gene.”
The paper relies on this without support.
Primary human neurons are difficult to obtain from human donors and cannot be expanded because they are post-mitotic.
“primary neurons are difficult to obtain from human donors, and non-expandable due to their post-mitotic nature.”
The paper relies on this without support.
Most previous CRISPR-based screens were conducted in cancer cell lines or stem cells rather than healthy differentiated human cells.
“Most previous CRISPR-based screens were implemented in cancer cell lines or stem cells rather than healthy differentiated human cells”
The paper relies on this without support.
CRISPRi reduces gene function by partial knockdown rather than complete knockout, allowing study of essential genes.
“Furthermore, CRISPRi perturbs gene function by partial knockdown, rather than knockout, thereby enabling the investigation of the biology of essential genes.”
The paper relies on this without support.
sgRNA abundance in pooled screens reflects cell survival or proliferation.
“Based on the depletion or enrichment of sgRNAs targeting specific genes at different time points compared to day 0, we identified hit genes for which knockdown was toxic or beneficial to either iPSCs or neurons at different time points (Fig. 2B, Fig. S2B).”
The paper relies on this without support.
iPSCs can be made from readily available cells, genetically engineered, expanded, and differentiated into various cell types.
“They can be made from readily available cells, such as skin fibroblasts or peripheral mononuclear blood cells; they can be genetically engineered and subsequently expanded to generate large numbers of isogenic cells; and they can then be differentiated into a variety of cell types”
The paper relies on this without support.
The presence of astrocytes in co-culture is representative of the brain environment.
“In the brain, many neuronal functions are supported by glial cells, particularly astrocytes.”
The paper relies on this without support.
CRISPR interference reduces gene expression partially rather than completely eliminating it.
“Third, it perturbs gene function via partial knockdown, as opposed to knockout”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CRISPR platforms have produced much larger genetic interaction maps than RNA interference, including CRISPRa gain-of-function maps and maps combining gain- and loss-of-function perturbations.
“This approach was pioneered in mammalian cells using RNA interference80,81, but CRISPR-based platforms have enabled the generation of substantially larger genetic interaction maps82, including CRISPRa-based gain-of-function maps83 and maps that combine gain- and loss-of-function perturbations to map directional pathways84.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Doxycycline concentration differs by a factor of 1,000
MinorThe neuronal-plating procedures specify 2 μg/μL doxycycline in Cortical Neuron Culture Medium, whereas the formulation of that same medium specifies 2 μg/mL.
“resuspended in Cortical Neuron Culture Medium with doxycycline (2 ug/uL)”
“and optionally 2μg/mL doxycycline.”
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · see citing works
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · see citing works
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849 · see citing works
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 12,617 · see citing works
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · see citing works
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · see citing works
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Carpenter, A. E., Jones, T. R., Lamprecht, M. R., Clarke, C., Kang, I. H., Friman, O., Guertin, D. A., Chang, J. H., Lindquist, R. A., Moffat, J., et al. (2006) · Genome biology · doi:10.1186/gb-2006-7-10-r100 · Cited by 5,077 · see citing works
Fast gene set enrichment analysisPreprint
Korotkevich, G., Sukhov, V., Budin, N., Shpak, B., Artyomov, M. N., & Sergushichev, A. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/060012 · Cited by 3,742 · see citing works
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · see citing works
Java Treeview—extensible visualization of microarray data
Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991 · see citing works
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856 · see citing works
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728 · see citing works
Self-citationLi, W., Xu, H., Xiao, T., Cong, L., Love, M. I., Zhang, F., Irizarry, R. A., Liu, J. S., Brown, M., & Liu, X. S. (2014) · Genome Biology · doi:10.1186/s13059-014-0554-4 · Cited by 2,684 · see citing works
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370 · see citing works
Dixit, A., Parnas, O., Li, B., Chen, J., Fulco, C. P., Jerby-Arnon, L., Marjanovic, N. D., Dionne, D., Burks, T., Raychowdhury, R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.038 · Cited by 1,863 · see citing works
McCarthy, D. J., Campbell, K. R., Lun, A. T. L., & Wills, Q. F. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btw777 · Cited by 1,852 · see citing works
WebGestalt: an integrated system for exploring gene sets in various biological contexts
Zhang, B., Kirov, S. A., & Snoddy, J. R. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki475 · Cited by 1,801 · see citing works
Rapid single-step induction of functional neurons from human pluripotent stem cells
Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., Marro, S., Patzke, C., Acuna, C., Covy, J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.029 · Cited by 1,644 · see citing works
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
Haapaniemi, E., Botla, S., Persson, J., Schmierer, B., & Taipale, J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0049-z · Cited by 1,264 · see citing works
Adamson, B., Norman, T. M., Jost, M., Cho, M. Y., Nuñez, J. K., Chen, Y., Villalta, J. E., Gilbert, L. A., Horlbeck, M. A., Hein, M. Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.048 · Cited by 1,193 · see citing works
Pooled CRISPR screening with single-cell transcriptome readout.
Datlinger, P., Rendeiro, A. F., Schmidl, C., Krausgruber, T., Traxler, P., Klughammer, J., Schuster, L. C., Kuchler, A., Alpar, D., & Bock, C. (2017) · Nature Methods · doi:10.1038/nmeth.4177 · Cited by 1,096 · see citing works
Koike-Yusa, H., Li, Y., Tan, E.-P., Velasco-Herrera, M. D. C., & Yusa, K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2800 · Cited by 1,064 · see citing works
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
Ihry, R. J., Worringer, K. A., Salick, M. R., Frias, E., Ho, D., Theriault, K., Kommineni, S., Chen, J., Sondey, M., Ye, C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0050-6 · Cited by 978 · see citing works
Horlbeck, M. A., Gilbert, L. A., Villalta, J. E., Adamson, B., Pak, R. A., Chen, Y., Fields, A. P., Park, C. Y., Corn, J. E., Kampmann, M., et al. (2016) · eLife · doi:10.7554/elife.19760 · Cited by 894 · see citing works
Self-citationHigh-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells
Zhou, Y., Zhu, S., Cai, C., Yuan, P., Li, C., Huang, Y., & Wei, W. (2014) · Nature · doi:10.1038/nature13166 · Cited by 733 · see citing works
Okita, K., Yamakawa, T., Matsumura, Y., Sato, Y., Amano, N., Watanabe, A., Goshima, N., & Yamanaka, S. (2013) · Stem Cells · doi:10.1002/stem.1293 · Cited by 710 · see citing works
Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens
Hart, T., Tong, A. H. Y., Chan, K., Van Leeuwen, J., Seetharaman, A., Aregger, M., Chandrashekhar, M., Hustedt, N., Seth, S., Noonan, A., et al. (2017) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.117.041277 · Cited by 599 · see citing works
Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons
Shi, Y., Lin, S., Staats, K. A., Li, Y., Chang, W.-H., Hung, S.-T., Hendricks, E., Linares, G. R., Wang, Y., Son, E. Y., et al. (2018) · Nature Medicine · doi:10.1038/nm.4490 · Cited by 566 · see citing works
Self-citationCRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs
Mandegar, M. A., Huebsch, N., Frolov, E. B., Shin, E., Truong, A., Olvera, M. P., Chan, A. H., Miyaoka, Y., Holmes, K., Spencer, C. I., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.01.022 · Cited by 525 · see citing works
Transcription factor-mediated differentiation of human iPSCs into neurons
Fernandopulle, M. S., Prestil, R., Grunseich, C., Wang, C., Gan, L., & Ward, M. E. (2018) · Current Protocols in Cell Biology · doi:10.1002/cpcb.51 · Cited by 461 · see citing works
Self-citationAdamson, B., Smogorzewska, A., Sigoillot, F. D., King, R. W., & Elledge, S. J. (2012) · Nature Cell Biology · doi:10.1038/ncb2426 · Cited by 433 · see citing works
Wang, C., Ward, M. E., Chen, R., Liu, K., Tracy, T. E., Chen, X., Xie, M., Sohn, P. D., Ludwig, C., Meyer-Franke, A., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.08.019 · Cited by 400 · see citing works
Self-citationA General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System
Iwamoto, M., Björklund, T., Lundberg, C., Kirik, D., & Wandless, T. J. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.07.009 · Cited by 391 · see citing works
CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine
Kampmann, M. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00657 · Cited by 371 · see citing works
Self-citationSchiroli, G., Conti, A., Ferrari, S., della Volpe, L., Jacob, A., Albano, L., Beretta, S., Calabria, A., Vavassori, V., Gasparini, P., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.02.019 · Cited by 342 · see citing works
Generation of pure GABAergic neurons by transcription factor programming
Yang, N., Chanda, S., Marro, S., Ng, Y.-H., Janas, J. A., Haag, D., Ang, C. E., Tang, Y., Flores, Q., Mall, M., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4291 · Cited by 341 · see citing works
Watkins, T. A., Wang, B., Huntwork, S., Yang, J. H., Jiang, Z., Eastham‐Anderson, J., Modrusan, Z. D., Kaminker, J. S., Tessier‐Lavigne, M., & Lewcock, J. W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211074110 · Cited by 330 · see citing works
A dual leucine kinase–dependent axon self-destruction program promotes Wallerian degeneration
Miller, B. R., Press, C., Daniels, R. W., Sasaki, Y., Milbrandt, J., & DiAntonio, A. (2009) · Nature Neuroscience · doi:10.1038/nn.2290 · Cited by 301 · see citing works
Isolation of single-base genome-edited human iPS cells without antibiotic selection
Miyaoka, Y., Chan, A. H., Judge, L. M., Yoo, J. C., Huang, M., Nguyen, T., Lizarraga, P. P., So, P.-L., & Conklin, B. R. (2014) · Nature Methods · doi:10.1038/nmeth.2840 · Cited by 292 · see citing works
On the design of CRISPR-based single-cell molecular screens
Hill, A. J., McFaline-Figueroa, J. L., Starita, L. M., Gasperini, M. J., Matreyek, K. A., Packer, J., Jackson, D., Shendure, J., & Trapnell, C. (2018) · Nature Methods · doi:10.1038/nmeth.4604 · Cited by 262 · see citing works
Neuritin: A gene induced by neural activity and neurotrophins that promotes neuritogenesis
Naeve, G. S., Ramakrishnan, M., Kramer, R., Hevroni, D., Citri, Y., & Theill, L. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2648 · Cited by 259 · see citing works
Welsbie, D. S., Yang, Z., Ge, Y., Mitchell, K. L., Zhou, X., Martin, S. E., Berlinicke, C. A., Hackler, L., Fuller, J., Fu, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211284110 · Cited by 247 · see citing works
Sengupta Ghosh, A., Wang, B., Pozniak, C. D., Chen, M., Watts, R. J., & Lewcock, J. W. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201103153 · Cited by 220 · see citing works
CRISPR Activation Screens Systematically Identify Factors that Drive Neuronal Fate and Reprogramming
Liu, Y., Chen, Y., Daley, T., Wang, F., Cao, W., Bhate, S. S., Lin, X., Still, C., Liu, H., Zhao, D., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.09.003 · Cited by 204 · see citing works
Hester, M. E., Murtha, M. J., Song, S., Rao, M., Miranda, C. J., Meyer, K., Tian, J., Boulting, G., Schaffer, D. V., Zhu, M. X., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.135 · Cited by 183 · see citing works
Use and Abuse of RNAi to Study Mammalian Gene Function
Kaelin, W. G. (2012) · Science · doi:10.1126/science.1225787 · Cited by 169 · see citing works
Postsynaptic CPG15 promotes synaptic maturation and presynaptic axon arbor elaboration in vivo
Cantallops, I., Haas, K. Z., & Cline, H. T. (2000) · Nature Neuroscience · doi:10.1038/79823 · Cited by 168 · see citing works
UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration
Groen, E. J. N., & Gillingwater, T. H. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.08.003 · Cited by 157 · see citing works
JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis
Huntwork-Rodriguez, S., Wang, B., Watkins, T., Ghosh, A. S., Pozniak, C. D., Bustos, D., Newton, K., Kirkpatrick, D. S., & Lewcock, J. W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201303066 · Cited by 154 · see citing works
Coordinated Motor Neuron Axon Growth and Neuromuscular Synaptogenesis Are Promoted by CPG15 In Vivo
Javaherian, A., & Cline, H. T. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.051 · Cited by 150 · see citing works
Valakh, V., Frey, E. N., Babetto, E., Walker, L. J., & DiAntonio, A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.014 · Cited by 130 · see citing works
Cerbini, T. A., Funahashi, R., Luo, Y., Liu, C., Park, K., Rao, M. S., Malik, N., & Zou, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116032 · Cited by 127 · see citing works
Willsey, A. J., Morris, M. T., Wang, S., Willsey, H. R., Sun, N., Teerikorpi, N., Baum, T., Cagney, G., Bender, K. J., Desai, T. A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.016 · Cited by 124 · see citing works
Self-citationKampmann, M., Bassik, M. C., & Weissman, J. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307002110 · Cited by 123 · see citing works
Self-citationDiverse reprogramming codes for neuronal identity
Tsunemoto, R. K., Lee, S., Szűcs, A. L., Chubukov, P., Sokolova, I., Blanchard, J., Eade, K., Bruggemann, J., Wu, C., Torkamani, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0103-5 · Cited by 122 · see citing works
Complementary information derived from CRISPR Cas9 mediated gene deletion and suppression
Rosenbluh, J., Xu, H., Harrington, W., Gill, S., Wang, X., Vázquez, F., Root, D. E., Tsherniak, A., & Hahn, W. C. (2017) · Nature Communications · doi:10.1038/ncomms15403 · Cited by 111 · see citing works
Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration
Pozniak, C. D., Ghosh, A. S., Gogineni, A., Hanson, J. E., Lee, S.-H., Larson, J. L., Solanoy, H. O., Bustos, D. J., Li, H., Ngu, H., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20122832 · Cited by 100 · see citing works
Larhammar, M., Huntwork-Rodriguez, S., Jiang, Z., Solanoy, H., Sengupta Ghosh, A., Wang, B., Kaminker, J. S., Huang, K., Eastham-Anderson, J., Siu, M., et al. (2017) · eLife · doi:10.7554/elife.20725 · Cited by 90 · see citing works
Luo, Y., Liu, C., Cerbini, T. A., San, H., Lin, Y., Chen, G., Rao, M. S., & Zou, J. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0212 · Cited by 88 · see citing works
Kampmann, M., Bassik, M. C., & Weissman, J. S. (2014) · Nature Protocols · doi:10.1038/nprot.2014.103 · Cited by 87 · see citing works
Self-citationProtein Prenylation Constitutes an Endogenous Brake on Axonal Growth
Li, H., Kuwajima, T., Oakley, D. H., Nikulina, E., Hou, J., Yang, W. S., Lowry, E. R., Lamas, N. J., Mathis, M. W., Croft, G. F., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.013 · Cited by 57 · see citing works
Sharma, K., Choi, S., Zhang, Y., Nieland, T. J. F., Long, S., Li, M., & Huganir, R. L. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.008 · Cited by 48 · see citing works
Nieland, T. J. F., Logan, D. J., Saulnier, J. L., Lam, D., Johnson, C. A., Root, D. E., Carpenter, A. E., & Sabatini, B. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091744 · Cited by 45 · see citing works
Neuritin Attenuates Cognitive Function Impairments in Tg2576 Mouse Model of Alzheimer's Disease
Choi, Y., Lee, K., Ryu, J., Kim, H. G., Jeong, A. Y., Woo, R., Lee, J.-H., Hyun, J. W., Hahn, S., Kim, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104121 · Cited by 41 · see citing works
Yao, J., Zhao, Q., Liu, D., Chow, C.-W., & Mei, Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.708883 · Cited by 35 · see citing works
A CRISPR Approach to Neurodegenerative Diseases
Kampmann, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.04.003 · Cited by 27 · see citing works
Self-citation
Flagged first, then by citations
1 of the 68 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
Nuñez, J. K., Chen, J., Pommier, G. C., Cogan, J. Z., Replogle, J. M., Adriaens, C., Ramadoss, G. N., Shi, Q., Hung, K. L., Samelson, A. J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.025 · Cited by 760 · see citing works
Self-citationMitochondrial stress is relayed to the cytosol by an OMA1–DELE1–HRI pathway
Guo, X., Aviles, G., Liu, Y., Tian, R., Unger, B. A., Lin, Y.-H. T., Wiita, A. P., Xu, K., Correia, M. A., & Kampmann, M. (2020) · Nature · doi:10.1038/s41586-020-2078-2 · Cited by 674 · see citing works
Self-citationLRP1 is a master regulator of tau uptake and spread
Rauch, J. N., Luna, G., Guzman, E., Audouard, M., Challis, C., Sibih, Y. E., Leshuk, C., Hernandez, I., Wegmann, S., Hyman, B. T., et al. (2020) · Nature · doi:10.1038/s41586-020-2156-5 · Cited by 541 · see citing works
Self-citationTDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
Brown, A., Wilkins, O. G., Keuss, M. J., Kargbo-Hill, S. E., Zanovello, M., Lee, W. C., Bampton, A., Lee, F. C. Y., Masino, L., Qi, Y. A., et al. (2022) · Nature · doi:10.1038/s41586-022-04436-3 · Cited by 526 · see citing works
Self-citationMolecular characterization of selectively vulnerable neurons in Alzheimer’s disease
Leng, K., Li, E., Eser, R., Piergies, A., Sit, R., Tan, M., Neff, N., Li, S. H., Rodriguez, R. D., Suemoto, C. K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00764-7 · Cited by 485 · see citing works
Self-citationInduced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452 · see citing works
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00862-0 · Cited by 414 · see citing works
Self-citationPredicting transcriptional outcomes of novel multigene perturbations with GEARS
Roohani, Y., Huang, K., & Leskovec, J. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01905-6 · Cited by 355 · see citing works
A reference human induced pluripotent stem cell line for large-scale collaborative studies
Pantazis, C. B., Yang, A., Lara, E., McDonough, J. A., Blauwendraat, C., Peng, L., Oguro, H., Kanaujiya, J., Zou, J., Sebesta, D., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.11.004 · Cited by 310 · see citing works
Self-citationA new era in functional genomics screens
Przybyla, L., & Gilbert, L. A. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00409-w · Cited by 281 · see citing works
Toxoplasma gondii infection and its implications within the central nervous system
Matta, S. K., Rinkenberger, N., Dunay, I. R., & Sibley, L. D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00518-7 · Cited by 259 · see citing works
A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states
Dräger, N. M., Sattler, S. M., Huang, C. T.-L., Teter, O. M., Leng, K., Hashemi, S. H., Hong, J., Aviles, G., Clelland, C. D., Zhan, L., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01131-4 · Cited by 258 · see citing works
Self-citationTruncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia
Prudencio, M., Humphrey, J., Pickles, S., Brown, A.-L., Hill, S. E., Kachergus, J. M., Shi, J., Heckman, M. G., Spiegel, M. R., Cook, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci139741 · Cited by 231 · see citing works
Self-citationGenomics, convergent neuroscience and progress in understanding autism spectrum disorder
Willsey, H. R., Willsey, A. J., Wang, B., & State, M. W. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00576-7 · Cited by 229 · see citing works
Neuronal enhancers are hotspots for DNA single-strand break repair
Wu, W., Kargbo-Hill, S. E., Nathan, W. J., Paiano, J., Callen, E., Wang, D., Shinoda, K., van Wietmarschen, N., Colón-Mercado, J. M., Zong, D., et al. (2021) · Nature · doi:10.1038/s41586-021-03468-5 · Cited by 223 · see citing works
Self-citationA cellular taxonomy of the adult human spinal cord
Yadav, A., Matson, K. J. E., Li, L., Hua, I., Petrescu, J., Kang, K., Alkaslasi, M. R., Lee, D. I., Hasan, S., Galuta, A., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.007 · Cited by 212 · see citing works
Self-citationHeterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity
Zhang, Y., Guo, L. E., Gonzales, P. K., Gendron, T. F., Wu, Y., Jansen‐West, K. R., O’Raw, A. D., Pickles, S. R., Prudencio, M., Carlomagno, Y., et al. (2019) · Science · doi:10.1126/science.aav2606 · Cited by 202 · see citing works
Self-citationCRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
Hendriks, D. F. G., Clevers, H. C., & Artegiani, B. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.10.014 · Cited by 196 · see citing works
scPerturb: harmonized single-cell perturbation data
Peidli, S., Green, T. D., Shen, C., Gross, T., Min, J., Garda, S., Yuan, B., Schumacher, L. J., Taylor-King, J. P., Marks, D. S., et al. (2024) · Nature Methods · doi:10.1038/s41592-023-02144-y · Cited by 194 · see citing works
Autophagy Assays for Biological Discovery and Therapeutic Development
Mizushima, N., & Murphy, L. O. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.07.006 · Cited by 192 · see citing works
Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD
Seddighi, S., Qi, Y. A., Brown, A., Wilkins, O. G., Bereda, C., Belair, C., Zhang, Y., Prudencio, M., Keuss, M. J., Khandeshi, A. J., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg7162 · Cited by 189 · see citing works
Self-citationWang, M., Li, A., Sekiya, M., Beckmann, N. D., Quan, X., Schrode, N., Fernando, M. B., Yu, A., Zhu, L., Cao, J., et al. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.002 · Cited by 185 · see citing works
Chen, J. J., Nathaniel, D. L., Raghavan, P., Nelson, M., Tian, R., Tse, E., Hong, J. Y., See, S. K., Mok, S.-A., Hein, M. Y., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009432 · Cited by 170 · see citing works
Self-citationTitrating gene expression using libraries of systematically attenuated CRISPR guide RNAs
Jost, M., Santos, D. A., Saunders, R. A., Horlbeck, M. A., Hawkins, J. S., Scaria, S. M., Norman, T. M., Hussmann, J. A., Liem, C. R., Gross, C. A., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0387-5 · Cited by 164 · see citing works
CRISPR-based functional genomics for neurological disease
Kampmann, M. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0373-z · Cited by 163 · see citing works
Self-citationGPNMB confers risk for Parkinson’s disease through interaction with α-synuclein
Diaz-Ortiz, M. E., Seo, Y., Posavi, M., Carceles Cordon, M., Clark, E., Jain, N., Charan, R., Gallagher, M. D., Unger, T. L., Amari, N., et al. (2022) · Science · doi:10.1126/science.abk0637 · Cited by 158 · see citing works
Leng, K., Rose, I. V. L., Kim, H., Xia, W., Romero‐Fernandez, W., Rooney, B., Koontz, M., Li, E., Ao, Y., Wang, S., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01180-9 · Cited by 154 · see citing works
Self-citationMaximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors
Replogle, J. M., Bonnar, J. L., Pogson, A. N., Liem, C. R., Maier, N. K., Ding, Y., Russell, B. J., Wang, X., Leng, K., Guna, A., et al. (2022) · eLife · doi:10.7554/elife.81856 · Cited by 150 · see citing works
Self-citationMaking neurons, made easy: The use of Neurogenin-2 in neuronal differentiation
Hulme, A. E., Maksour, S., Clair‐Glover, M. S., Miellet, S., & Dottori, M. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.11.015 · Cited by 147 · see citing works
Neurons require glucose uptake and glycolysis in vivo
Li, H., Guglielmetti, C., Sei, Y. J., Zilberter, M. Y., Page, L. M. L., Shields, L. Y., Yang, J. L., Nguyen, K., Tiret, B., Gao, X. Z., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112335 · Cited by 143 · see citing works
Self-citationBinan, L., Jiang, A., Danquah, S. A., Valakh, V., Simonton, B., Bezney, J., Manguso, R. T., Yates, K. B., Nehme, R., Cleary, B., et al. (2025) · Cell · doi:10.1016/j.cell.2025.02.012 · Cited by 141 · see citing works
Fernandes, H. J. R., Patikas, N., Foskolou, S., Field, S. F., Park, J.-E., Byrne, M. L., Bassett, A. R., & Metzakopian, E. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108263 · Cited by 138 · see citing works
Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases
Kampmann, M. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00806-0 · Cited by 138 · see citing works
Self-citationEmerging trends in organ-on-a-chip systems for drug screening
Wang, Y., Gao, Y., Pan, Y., Zhou, D., Liu, Y., Yin, Y. B., Yang, J., Wang, Y., & Song, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.02.006 · Cited by 130 · see citing works
CRISPR/Cas-Based Epigenome Editing: Advances, Applications, and Clinical Utility
Goell, J., & Hilton, I. B. (2021) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.10.012 · Cited by 125 · see citing works
Functional regulatory variants implicate distinct transcriptional networks in dementia
Cooper, Y. A., Teyssier, N., Dräger, N. M., Guo, Q., Davis, J. E., Sattler, S. M., Yang, Z., Patel, A. M., Wu, S. J., Kosuri, S., et al. (2022) · Science · doi:10.1126/science.abi8654 · Cited by 120 · see citing works
Self-citationA comprehensive resource for induced pluripotent stem cells from patients with primary tauopathies
Karch, C. M., Kao, A. W., Karydas, A., Onanuga, K., Martinez, R., Argouarch, A., Wang, C., Huang, C., Sohn, P. D., Bowles, K. R., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.09.006 · Cited by 119 · see citing works
Self-citationWells, M. F., Nemesh, J., Ghosh, S., Mitchell, J. M., Salick, M. R., Mello, C. J., Meyer, D., Pietilainen, O., Piccioni, F., Guss, E. J., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.01.010 · Cited by 116 · see citing works
Active DNA demethylation promotes cell fate specification and the DNA damage response
Wang, D., Wu, W., Callen, E., Pavani, R., Zolnerowich, N., Kodali, S., Zong, D., Wong, N., Noriega, S., Nathan, W. J., et al. (2022) · Science · doi:10.1126/science.add9838 · Cited by 113 · see citing works
Self-citationBassil, R., Shields, K., Granger, K., Zein, I., Ng, S., & Chih, B. (2021) · Nature Communications · doi:10.1038/s41467-021-25344-6 · Cited by 106 · see citing works
Organ‐On‐A‐Chip Models of the Blood–Brain Barrier: Recent Advances and Future Prospects
Kawakita, S., Mandal, K., Mou, L., Mecwan, M. M., Zhu, Y., Li, S., Sharma, S., Hernández, A. L., Nguyen, H. T., Maity, S., et al. (2022) · Small · doi:10.1002/smll.202201401 · Cited by 101 · see citing works
Giacomelli, E., Vahsen, B. F., Calder, E. L., Xu, Y., Scaber, J., Gray, E., Dafinca, R., Talbot, K., & Studer, L. (2022) · Cell stem cell · doi:10.1016/j.stem.2021.12.008 · Cited by 97 · see citing works
Association of a common genetic variant with Parkinson’s disease is mediated by microglia
Langston, R. G., Beilina, A., Reed, X., Kaganovich, A., Singleton, A. B., Blauwendraat, C., Gibbs, J. R., & Cookson, M. R. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abp8869 · Cited by 93 · see citing works
Base editing screens map mutations affecting interferon-γ signaling in cancer
Coelho, M. A., Cooper, S., Strauß, M. E., Karakoç, E., Bhosle, S. G., Gonçalves, E., Picco, G., Burgold, T., Cattaneo, C. M., Veninga, V., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2022.12.009 · Cited by 93 · see citing works
Oltion, K., Carelli, J. D., Yang, T., See, S. K., Wang, H., Kampmann, M., & Taunton, J. (2023) · Cell · doi:10.1016/j.cell.2022.12.025 · Cited by 90 · see citing works
Self-citationPace, R. D., Britt, D. J., Mercurio, J. C., Foster, A. M., Djavaherian, L., Hoffmann, V. J., Abebe, D. T., & Bonifacino, J. S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107775 · Cited by 89 · see citing works
Lalli, M. A., Avey, D. R., Dougherty, J. D., Milbrandt, J., & Mitra, R. D. (2020) · Genome Research · doi:10.1101/gr.262295.120 · Cited by 89 · see citing works
Li, Y., Dou, X., Liu, J., Xiao, Y., Zhang, Z., Hayes, L. R., Wu, R., Fu, X., Ye, Y., Yang, B., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01374-9 · Cited by 82 · see citing works
Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
Hayes, L. R., & Kaláb, P. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01260-5 · Cited by 81 · see citing works
Human iPSC 4R tauopathy model uncovers modifiers of tau propagation
Bravo, C., Giani, A. M., Madero‐Pérez, J., Zhao, Z., Wan, Y., Samelson, A. J., Wong, M. Y., Evangelisti, A., Cordes, E., Fan, L., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.015 · Cited by 81 · see citing works
Self-citationImage-based pooled whole-genome CRISPRi screening for subcellular phenotypes
Kanfer, G., Sarraf, S. A., Maman, Y., Baldwin, H. A., Domínguez‐Martín, E., Johnson, K. R., Ward, M. E., Kampmann, M., Lippincott‐Schwartz, J., & Youle, R. J. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202006180 · Cited by 78 · see citing works
Self-citationBRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2
Samelson, A. J., Tran, Q. D., Robinot, R., Carrau, L., Rezelj, V. V., Kain, A. M., Chen, M., Ramadoss, G. N., Guo, X., Lim, S. A., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-021-00821-8 · Cited by 76 · see citing works
Self-citationA functional genetic toolbox for human tissue-derived organoids
Sun, D., Evans, L., Perrone, F., Sokleva, V., Lim, K., Rezakhani, S., Lutolf, M., Zilbauer, M., & Rawlins, E. L. (2021) · eLife · doi:10.7554/elife.67886 · Cited by 71 · see citing works
Black, J. B., McCutcheon, S. R., Dube, S., Barrera, A., Klann, T. S., Rice, G., Adkar, S. S., Soderling, S. H., Reddy, T. E., & Gersbach, C. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108460 · Cited by 71 · see citing works
De Novo VPS4A Mutations Cause Multisystem Disease with Abnormal Neurodevelopment
Rodger, C. E., Flex, E., Allison, R. J., Sanchis‐Juan, A., Hasenahuer, M. A., Cecchetti, S., French, C. E., Edgar, J. R., Carpentieri, G., Ciolfi, A., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.10.012 · Cited by 69 · see citing works
Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies
McTague, A., Rossignoli, G., Ferrini, A., Barral, S., & Kurian, M. A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.630600 · Cited by 67 · see citing works
TDP-43 loss induces cryptic polyadenylation in ALS/FTD
Bryce-Smith, S., Brown, A., Chien, M. Z. Y. J., Dattilo, D., Mehta, P. R., Mattedi, F., Barattucci, S., Mikheenko, A., Zanovello, M., Pellegrini, F., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02050-w · Cited by 65 · see citing works
CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis
Samelson, A. J., Ariqat, N., McKetney, J., Rohanitazangi, G., Bravo, C., Bose, R., Travaglini, K. J., Lam, V. L., Goodness, D., Ta, T., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.038 · Cited by 65 · see citing works
Self-citationA Presynaptic Perspective on Transport and Assembly Mechanisms for Synapse Formation
Rizalar, F. S., Roosen, D. A., & Haucke, V. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.038 · Cited by 63 · see citing works
Soutar, M. P. M., Melandri, D., O’Callaghan, B., Annuario, E., Monaghan, A. E., Welsh, N. J., D’Sa, K., Guelfi, S., Zhang, D., Pittman, A. M., et al. (2022) · Brain · doi:10.1093/brain/awac325 · Cited by 62 · see citing works
Developing nociceptor-selective treatments for acute and chronic pain
Jayakar, S. S., Shim, J., Jo, S., Bean, B. P., Singeç, I., & Woolf, C. J. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj9837 · Cited by 60 · see citing works
The frontier of live tissue imaging across space and time
Huang, Q., Garrett, A., Bose, S., Blocker, S. J., Rios, A. C., Clevers, H. C., & Shen, X. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.02.010 · Cited by 59 · see citing works
Viñas Torné, R., Wiatrak, M., Piran, Z., Fan, S., Jiang, L., Teichmann, S. A., Nitzan, M., & Brbić, M. (2026) · Nature Biotechnology · doi:10.1038/s41587-025-02777-8 · Cited by 58 · see citing works
Lai, J. D., Berlind, J. E., Fricklas, G., Lie, C., Urenda, J., Lam, K., Maria, N. S. S., Jacobs, R. E., Yu, V. L., Zhao, Z., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.03.004 · Cited by 58 · see citing works
Gowrishankar, S., Lyons, L. L., Rafiq, N. M., Roczniak-Ferguson, A., Camilli, P. V. D., & Ferguson, S. M. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-06-0382 · Cited by 57 · see citing works
Dual inhibition of TMPRSS2 and Cathepsin B prevents SARS-CoV-2 infection in iPS cells
Hashimoto, R., Sakamoto, A., Deguchi, S., Yi, R., Sano, E., Hotta, A., Takahashi, K., Yamanaka, S., & Takayama, K. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.10.016 · Cited by 56 · see citing works
Gaucher disease provides a unique window into Parkinson disease pathogenesis
Hertz, E., Chen, Y., & Sidransky, E. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00999-z · Cited by 56 · see citing works
Single-cell mapping of lipid metabolites using an infrared probe in human-derived model systems
Bai, Y., Camargo, C. M., Glasauer, S. M. K., Gifford, R., Tian, X., Longhini, A. P., & Kosik, K. S. (2024) · Nature Communications · doi:10.1038/s41467-023-44675-0 · Cited by 55 · see citing works
CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma
Ramkumar, P., Abarientos, A., Tian, R., Seyler, M., Leong, J. T., Chen, M., Choudhry, P., Hechler, T., Shah, N. D., Wong, S. W. K., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001346 · Cited by 54 · see citing works
Self-citationMoving from in vitro to in vivo CRISPR screens
Kuhn, M., Santinha, A. J., & Platt, R. J. (2021) · Gene and Genome Editing · doi:10.1016/j.ggedit.2021.100008 · Cited by 53 · see citing works
A fully automated FAIMS-DIA mass spectrometry-based proteomic pipeline
Reilly, L., Lara, E., Ramos, D. M., Li, Z., Pantazis, C. B., Stadler, J., Santiana, M., Roberts, J. L., Faghri, F., Hao, Y., et al. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100593 · Cited by 52 · see citing works
Self-citationMassively parallel techniques for cataloguing the regulome of the human brain
Townsley, K. G., Brennand, K., & Huckins, L. M. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00740-1 · Cited by 52 · see citing works
Neurodegeneration cell per cell
Balusu, S., Praschberger, R., Lauwers, E., Strooper, B. D., & Verstreken, P. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.016 · Cited by 51 · see citing works
Sen, T., & Thummer, R. P. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00564-w · Cited by 50 · see citing works
Zhang, Z., Wang, X., Park, S. S., Song, H., & Ming, G. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.12.015 · Cited by 49 · see citing works
Strategies to Promote Long-Distance Optic Nerve Regeneration
Yang, S.-G., Li, C.-P., Peng, X.-Q., Teng, Z., Liu, C.-M., & Zhou, F. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00119 · Cited by 49 · see citing works
NudC guides client transfer between the Hsp40/70 and Hsp90 chaperone systems
Biebl, M. M., Delhommel, F., Faust, O., Żak, K. M., Agam, G. N., Guo, X., Mühlhofer, M., Dahiya, V., Hillebrand, D., Popowicz, G. M., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.031 · Cited by 48 · see citing works
Self-citationModeling Psychiatric Disorder Biology with Stem Cells
Das, D., Feuer, K. L., Wahbeh, M. H., & Avramopoulos, D. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01148-1 · Cited by 47 · see citing works
FMRP regulates MFF translation to locally direct mitochondrial fission in neurons
Fenton, A. R., Peng, R., Bond, C., Hugelier, S., Lakadamyali, M., Chang, Y., Holzbaur, E. L. F., & Jongens, T. A. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01544-2 · Cited by 47 · see citing works
Modeling the complex genetic architectures of brain disease
Fernando, M. B., Ahfeldt, T., & Brennand, K. (2020) · Nature Genetics · doi:10.1038/s41588-020-0596-3 · Cited by 47 · see citing works
Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages
Navarro‐Guerrero, E., Tay, C., Whalley, J. P., Cowley, S. A., Davies, B., Knight, J. C., & Ebner, D. V. (2021) · Scientific Reports · doi:10.1038/s41598-021-82137-z · Cited by 47 · see citing works
High-resolution characterization of gene function using single-cell CRISPR tiling screen
Yang, L., Chan, A. K. N., Miyashita, K., Delaney, C. D., Wang, X., Li, H., Pokharel, S. P., Li, S., Li, M., Xu, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24324-0 · Cited by 45 · see citing works
Moysés‐Oliveira, M., Yadav, R., Erdin, S., & Talkowski, M. E. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.07.001 · Cited by 45 · see citing works
Creation of de novo cryptic splicing for ALS and FTD precision medicine
Wilkins, O. G., Chien, M. Z. Y. J., Wlaschin, J. J., Barattucci, S., Harley, P., Mattedi, F., Mehta, P. R., Pisliakova, M., Ryadnov, E. M., Keuss, M. J., et al. (2024) · Science · doi:10.1126/science.adk2539 · Cited by 44 · see citing works
Lee, S., McAfee, J. C., Lee, J., Gomez, A., Ledford, A. T., Clarke, D., Min, H., Gerstein, M., Boyle, A. P., Sullivan, P. F., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.022 · Cited by 44 · see citing works
Exploiting CRISPR Cas9 in Three-Dimensional Stem Cell Cultures to Model Disease
Gopal, S., Rodrigues, A. L., & Dordick, J. S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00692 · Cited by 44 · see citing works
CRISPR-based functional genomics screening in human-pluripotent-stem-cell-derived cell types
Li, K., Ouyang, M., Zhan, J., & Tian, R. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100300 · Cited by 42 · see citing works
Self-citationLoss of TDP-43 induces synaptic dysfunction that is rescued by UNC13A splice-switching ASOsPreprint
Keuss, M. J., Harley, P., Ryadnov, E. M., Jackson, R. E., Zanovello, M., Wilkins, O. G., Barattucci, S., Mehta, P. R., Oliveira, M. G., Parkes, J. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.20.599684 · Cited by 42 · see citing works
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2020) · doi:10.1101/2020.06.27.175679 · Cited by 414 · see citing works
Self-citationFerguson, R., Goold, R., Coupland, L. A., Flower, M. D., & Tabrizi, S. J. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.04.015 · Cited by 41 · see citing works
Mulvey, B., Lagunas, T., & Dougherty, J. D. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.011 · Cited by 40 · see citing works
Massively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution
Cheng, J., Lin, G., Wang, T., Wang, Y., Guo, W., Liao, J., Yang, P., Chen, J., Shao, X., Lu, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202204484 · Cited by 40 · see citing works
SOX9 maintains human foetal lung tip progenitor state by enhancing WNT and RTK signalling
Sun, D., Llora Batlle, O., van den Ameele, J., Thomas, J. C., He, P., Lim, K., Tang, W., Xu, C., Meyer, K. B., Teichmann, S. A., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022111338 · Cited by 38 · see citing works
Teter, O. M., McQuade, A., Hagan, V., Liang, W., Dräger, N. M., Sattler, S. M., Holmes, B. B., Castillo, V. C., Papakis, V., Leng, K., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02997-z · Cited by 38 · see citing works
Self-citationAscl1 and Ngn2 convert mouse embryonic stem cells to neurons via functionally distinct paths
Vainorius, G., Novatchkova, M., Michlits, G., Baar, J. C., Raupach, C., Lee, J., Yelagandula, R., Wernig, M., & Elling, U. (2023) · Nature Communications · doi:10.1038/s41467-023-40803-y · Cited by 38 · see citing works
Zhou, X., Lee, Y.-K., Li, X., Kim, H., Sánchez-Priego, C., Han, X., Tan, H., Zhou, S., Fu, Y., Purtell, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47440-z · Cited by 38 · see citing works
Functional Characterisation of a GWAS Risk Locus Identifies GPX3 as a Lead Candidate Gene in ALS
Restuadi, R., Steyn, F. J., Kabashi, E., Ngo, S. T., Cheng, F., Nabais, M. F., Thompson, M. J., Qi, T., Wu, Y., Henders, A. K., et al. (2020) · Genome Medicine · doi:10.1186/s13073-021-01006-6 · Cited by 38 · see citing works
Mitochondrial YME1L1 governs unoccupied protein translocase channels
Hsu, M.-C., Kinefuchi, H., Lei, L., Kikuchi, R., Yamano, K., & Youle, R. J. (2025) · Nature Cell Biology · doi:10.1038/s41556-024-01571-z · Cited by 37 · see citing works
Application of CRISPR genetic screens to investigate neurological diseases
So, R. W. L., Chung, S., Lau, H. H. C., Watts, J. J., Gaudette, E. V., Al‐Azzawi, Z. A. M., Bishay, J., Lin, L. T., Joung, J., Wang, X., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0343-3 · Cited by 36 · see citing works
Local production of reactive oxygen species drives vincristine-induced axon degeneration
Gómez-Deza, J., Slavutsky, A. L., Nebiyou, M., & Pichon, C. E. L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06227-8 · Cited by 35 · see citing works
- Authors
- Tian, R., Gachechiladze, M. A., Ludwig, C. H., Laurie, M. T., Hong, J. Y., Nathaniel, D., Prabhu, A. V., Fernandopulle, M. S., Patel, R., Abshari, M., Ward, M. E., & Kampmann, M.
- Affiliations
- University of California, San Francisco (US)
- National Institutes of Health (US)
- Corresponding author
- Ward, Michael E.
- Kampmann, Martin
- ORCID
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 104
- Issue
- 2
- Pages
- 239-255.e12
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC6813890
- OpenAlex
- W2967789674
- Cited by
- 543
- References
- 68
- Citations by year
- 2026: 85 · 2025: 116 · 2024: 103 · 2023: 60 · 2022: 66 · 2021: 62 · 2020: 45 · 2019: 6
- FWCI
- 15.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of General Medical Sciences
- Paul G. Allen Family Foundation
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- CRISPR interference, iPSC-derived neurons, functional genetic screens, gene knockdown, neuronal survival, essential genes, single-cell transcriptomics, neuronal morphology
- MeSH terms
- RNA-Seq, Cell Survival, Humans, Neurons, Microscopy, Confocal, Gene Knockdown Techniques, Induced Pluripotent Stem Cells, Single-Cell Analysis, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review